Company: CDLX
Filing Date: 2025-05-20
Form Type: 8-K
Source: 0001666071-25-000075
Chunk: 1

Company: Cardlytics, Inc.
Filing Date: 2025-05-20
Form: 8-K
Item: Item 5.07
Chunk 1
---
ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

The Annual Meeting of the Company was held on May 20, 2025. The stockholders considered four proposals, each of which is described in more detail in the Proxy Statement. Of the 52,174,481 shares outstanding as of March 26, 2025 (the "record date"), 34,079,352 shares, or 65.31% of the shares outstanding as of the record date, were present or represented by proxy at the Annual Meeting. Set forth below are the results of the matters submitted for a vote of stockholders at the Annual Meeting.

Proposal No. 1: Election of the three nominees of the Company's board of directors (the "Board") to serve as Class I directors, each to hold office until the 2028 annual meeting of stockholders and until their respective successors are elected and qualified. The votes were cast as follows:

  Name               Votes For                      Votes Withheld                 
 ───────────────────────────────────────────────────────────────────────────────────
  Jon Francis                       20,512,742                          1,820,582  
  Scott Hill                        20,964,434                          1,368,890  
  Alex Mishurov                     19,645,866                          2,687,458  

Broker Non-Votes: 11,746,028

Accordingly, all nominees were elected to serve as Class I directors.

Proposal No. 2: Ratification of the selection by the audit committee of the Board of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. The votes were cast as follows:

                                                          Votes For                      Votes Against                   Abstained               
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Ratification of Selection of Deloitte & Touche LLP                     33,108,069                         582,804                     388,479  

Accordingly, the Company's stockholders approved Proposal No. 2.

Proposal No. 3: Approval of the Cardlytics, Inc. 2025 Equity Incentive Plan.

                                                               Votes For                      Votes Against                     Abstained               
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Approval of Cardlytics, Inc. 2025 Equity Incentive Plan